Information Provided By:
Fly News Breaks for March 3, 2020
CODX
Mar 3, 2020 | 08:51 EDT
Maxim analyst Jason McCarthy downgraded Co-Diagnostics to Hold from Buy. The analyst notes that amid the outbreak of coronavirus, the need for more diagnostic testing offers the company's COVID-19 rapidly developed and CE Mark approved test a "significant opportunity". However, with the shares having risen from $20M to $450M, he questions just how much further the valuation on Co-Diagnostics stock can go.
News For CODX From the Last 2 Days
There are no results for your query CODX